This track will explore the mechanisms of oncogenesis and the role of cancer stem cells in tumor initiation and progression. Research highlighting the implications of these findings for targeted therapies will be emphasized.

This session will focus on the processes of malignant transformation and the genetic and environmental factors that contribute to mutagenesis. Presentations will include novel insights into the molecular pathways involved in these phenomena.

This track will showcase cutting-edge research in cancer medical science, including innovative diagnostic and therapeutic strategies. Emphasis will be placed on translational research that bridges laboratory findings with clinical applications.

This session will delve into the latest advancements in molecular oncology, focusing on the integration of analytics in understanding cancer biology. Discussions will include the use of big data and bioinformatics in cancer research.

This track will address the disparities in cancer incidence, treatment, and outcomes among different populations. Research aimed at understanding and mitigating these disparities will be a central theme.

This session will highlight novel approaches in cancer treatment and management, including personalized medicine and combination therapies. The focus will be on improving patient outcomes through innovative strategies.

This track will cover best practices in the clinical management of cancer patients, including multidisciplinary approaches to care. Case studies and clinical trials will be discussed to illustrate effective management strategies.

This session will explore the intersection of immunology and oncology, focusing on the development of immunotherapeutic strategies. Research on the mechanisms of immune evasion by tumors will also be presented.

This track will investigate the role of viral infections in cancer pathogenesis, including mechanisms of viral oncogenesis. Studies on prevention and therapeutic interventions targeting viral-associated cancers will be featured.

This session will examine the impact of environmental carcinogens on cancer risk and the strategies for cancer prevention. Research on public health initiatives and policy implications will be discussed.

This track will focus on the development of chemical therapeutics and advancements in cancer imaging technologies. Presentations will cover novel agents and imaging techniques that enhance diagnosis and treatment monitoring.